Embecta Corp. (EMBC) Faces Securities Class Action Over Insulin Pen Needle Disclosure - Investors with Losses Encouraged to Contact HBSS

SAN FRANCISCO, July 31, 2026 /PRNewswire/ -- Hagens Berman, a leading national shareholder rights law firm, is conducting an investigation into Embecta Corp. (NASDAQ: EMBC) regarding alleged violations of federal securities laws. This investigation follows the recent filing of a class...